Topical imiquimod monotherapy for indolent primary cutaneous B‐cell lymphomas: a single‐institution experience. (25th March 2020) - Hwang, S.; Johnson, A.; Fabbro, S.; Hastings, J.; Haverkos, B.; Chung, C.; Porcu, P.; William, B.